Cited by 244Autoimmune and Inflammatory Disorders ResearchKawasaki Disease and Coronary ComplicationsImmunodeficiency and Autoimmune Disorders

Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: Report of five cases

Mouy, Richard, Stephan, Jean-Louis, Pillet, Pascal, Haddad, Elie, Hubert, Philippe, Prieur, Anne-Marie·1996·The Journal of Pediatrics

Abstract

Objectives To evaluate the efficacy of cyclosporine A in the treatment of macrophage activation syndrome (MAS) occurring in children with juvenile arthritis.Study design MAS developed in two boys and three girls with systemic juvenile arthritis (four) and polyarticular juvenile arthritis (one). In three children whose condition was life-threatening, increased parenteral administration of corticosteroids failed to improve their condition; therefore cyclosporine A (2 to 5 mg/kg per day) was added. In two other patients with less severe clinical manifestations, cyclosporine A alone (2 to 8 mg/kg per day) was given.Results After the introduction of cyclosporine A, rapid improvement was obtained in all patients and apyrexia occurred within 24 to 48 hours. The biologic abnormalities disappeared more slowly (up to 5 weeks for liver enzymes).Conclusions These observations underline the usefulness of cyclosporine A in this complication. The use of this drug may circumvent the need for increased doses of corticosteroids in some patients. The mechanism of action of cyclosporine A remains speculative, but these results indicate indirectly that T-helper lymphocytes may play a role in the pathogenesis of MAS.

Integrity signals

Registry

Crossref · 10.1016/s0022-3476(96)70160-9

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nonablative inhibition of T cells with cyclosporine can also be helpful.

    “Nonablative inhibition of T cells with cyclosporine can also be helpful.77”

    From Cytokine storm (2020) · cites this paper as [77]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mouy, R., Stephan, J.-L., Pillet, P., Haddad, E., Hubert, P., & Prieur, A.-M.
Affiliations
Hôpital Necker-Enfants Malades (FR)
Venue
The Journal of Pediatrics
Publisher
Elsevier BV
Published
1996-11
Volume
129
Issue
5
Pages
750-754
ISSN
0022-3476 (ISSN-L)
OpenAlex
W2062603648
Cited by
244
References
25
Citations by year
2026: 4 · 2025: 3 · 2024: 8 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 13 · 2019: 7 · 2018: 7 · 2017: 9 · 2016: 13 · 2015: 15 · 2014: 11 · 2013: 9 · 2012: 9
FWCI
2.60
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Pediatrics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
  • Health Sciences › Medicine › Surgery › Kawasaki Disease and Coronary Complications
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Keywords
cyclosporine, macrophage activation syndrome, juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, corticosteroid-refractory disease, T helper cells, liver enzymes
MeSH terms
Arthritis, Juvenile, Child, Child, Preschool, Female, Humans, Immunosuppressive Agents, Macrophage Activation, Male, Syndrome, Cyclosporine, Treatment Outcome, Antirheumatic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review